Transcatheter Mitral Valve Replacement in Patients with Mitral Annular Calcification: A Review

Ankit Agrawal1, Michael J Reardon2, Sachin S Goel2

  • 1Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.

Heart International
|July 17, 2023
PubMed

Insights

Mitral annular calcification (MAC) poses surgical risks. Transcatheter mitral valve replacement (TMVR) offers an alternative for high-risk patients, but requires careful imaging to prevent complications.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Mitral annular calcification (MAC) is a degenerative condition affecting the mitral valve (MV).
  • MAC is linked to mitral stenosis and/or regurgitation.
  • Patients with MAC often face high risks with traditional mitral valve surgery.

Purpose of the Study:

  • To review the pathology of MAC.
  • To highlight the role of preprocedural imaging in patient selection for TMVR.
  • To discuss clinical outcomes and complications of TMVR in MAC patients.

Main Methods:

  • Review of existing literature on transcatheter mitral valve replacement (TMVR) in MAC.
  • Emphasis on multimodality imaging for anatomical assessment.
  • Analysis of clinical outcomes and complication profiles.

Main Results:

  • TMVR, including valve-in-MAC, is a viable option for high-risk surgical patients.
  • Thorough preprocedural imaging is crucial for successful TMVR.
  • Potential complications include left ventricular outflow tract obstruction and paravalvular regurgitation.

Conclusions:

  • TMVR provides a treatment alternative for patients with MAC unsuitable for surgery.
  • Optimal patient selection via imaging is key to minimizing TMVR risks.
  • Understanding MAC pathology and TMVR complications is essential for interventional cardiologists.

Related Concept Videos